Back

The impact of type 2 diabetes on short term myocardial morphological, functional, and energetic recovery post coronary artery bypass surgery in patients with ischemic heart disease

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification and treatment in patients undergoing CABG Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Sindhoora Kotha

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Clinical impact of Sarcopenia on long-term mortality in patients undergoing coronary bypass grafting
Doctor J. Jo (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Colchicine in patients with coronary disease undergoing coronary artery bypass surgery: a meta-analysis of randomized controlled trials
Doctor H. Kirov (Jena, DE)
Abstract Slides Video
Presentation thumbnail
The utility of angiography-derived fractional flow reserve in predicting graft occlusions prior to bypass surgery
Doctor M. Buske (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
A randomized controlled trial of an eight-week cardiac rehabilitation home verse hospital exercise programme for post coronary cardiac bypass patients
Doctor M. Takroni (Riyadh, SA)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification and treatment in patients undergoing CABG

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Impaired strain in diabetic patients with stable coronary artery disease assessed by cardiac magnetic resonance
thumbnail
Congress Presentation
Type 2 diabetes individuals have a shorter QRS duration, prolonged QTc interval, flatter T wave, and reduced left ventricular cycle volumes compared to matched controls in the UK Biobank
thumbnail
Congress Presentation
Diabetes worsens the adverse association between myocardial diffuse fibrosis and left ventricular strain.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources